Follow-up of women with inadequate Pap smears
a prospective cohort study
Keywords:
Cell biology, Vaginal smears, Uterine cervical neoplasms, Health planning guidelines, Follow-up studiesAbstract
CONTEXT AND OBJECTIVE: Inadequate Pap smears do not provide satisfactory cell samples for evalua-tion, thus making it more difficult to detect cervical cytological abnormalities. The objective of this study was to determine the cytological and histological follow-up results from women with inadequate smear reports in primary healthcare centers in Santiago, Chile 2010-2011. DESIGN AND SETTING: Prospective cohort study at primary healthcare clinics in Santiago, Chile. METHODS: The population was taken from the “Cito-Expert” database of 2010. The data were then or-ganized according to the cytological and histological follow-up results of 2,547 women with inadequate cervical cytological reports over the 12-month period. The samples were assigned to groups based on the cause of inadequacy (smears with endocervical cells alone; insufficient, hemorrhagic, inflammatory or poorly fixed samples; insufficient and hemorrhagic samples; or insufficient and inflammatory specimens). The data were analyzed using the “conditional probability tree diagram” and descriptive statistics. RESULT: Half of the women (n = 1,285) met the requirements of the Ministry of Health for repeating these inadequate smears, and 1,104 of these women had normal cytological results (85.9%). The detection rate for cervical lesions according to group ranged from 0% (smears with endocervical cells alone or insuf-ficient and hemorrhagic specimens) to 4.1% (poor fixation). CONCLUSION: The large proportion of normal results justifies revision of the current clinical guidelines. The results showed that it is not necessary to repeat the Pap test early on, with the exception of inadequate hemorrhagic and inflammatory cytological results.
Downloads
References
Ministerio de Salud de Chile. Departamento Programa de las Personas. Orientaciones para la pesquisa y control de cáncer cérvicouterino en Chile. Santiago de Chile. El Ministerio; 1998. Available from: http://biblio.uchile.cl/client/en_US/sisib/search/detailnonmodal/ent:$002f$002fSD_ILS$002f283$002fSD_ILS:283090/ada;jsessionid=037921DFCA355735A2C8421A682B26C5?qu=NEOPLASMAS+DEL+CUELLO+UTERINO+--+TERAPIA.&ic=true. Accessed in 2013 (Nov 18).
Ministerio de Salud de Chile. Terminologia para el informe citologico de muestras cervicales (PAP). Available from: http://www.redsalud.gov.cl/archivos/cancer/Informa_cambio_Nomenclatura_2005.pdf. Accessed in 2013 (Nov 18).
Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002;287(16):2114-9.
González Losa M del R, Amaro Camacho A, Domínguez Reyes M, Castro Sansores CJ. Calidad de la toma de muestra de citologia cervical de la Unidad Médica de Medicina Familiar No. 57 del Instituto Mexicano del Seguro Social. Rev Biomed. 2006;17(2):102-6. Available from: http://www.imbiomed.com/1/1/articulos.php?method=showDetail&id_articulo=37839&id_seccion=383&id_ejemplar=3904&id_revista=22. Accessed in 2013 (Nov 19).
Cendales R, Wiesner C, Murillo RH, et al. La calidad de las citologías para tamización de cáncer de cuello uterino en cuatro departamentos de Colombia: un estudio de concordancia. [Quality of vaginal smear for cervical cancer screening: a concordance study]. Biomédica (Bogotá). 2009;30(1):107-15.
Amaral RG, Manrique EJC, Guimarães JV, et al. Influência da adequabilidade da amostra sobre a detecção das lesões precursoras do câncer cervical [Influence of adequacy of the sample on detection of the precursor lesions of the cervical cancer]. Rev Bras Ginecol Obstet. 2008;30(11):556-60.
Adams AL, Gidley J, Roberson J, et al. Clinical significance of unsatisfactory conventional pap smears owing to inadequate squamous cellularity defined by the Bethesda 2001 criterion. Am J Clin Pathol. 2005;123(5):738-43.
Elumir-Tanner L, Doraty M; Southern Alberta Primary Care Research Network (SAPCReN). Management of Papanicolaou test results that lack endocervical cells. CMAJ. 2011;183(5):563-8.
Elit L, Krzyzanowska M, Saskin R, et al. Sociodemographic factors associated with cervical cancer screening and follow-up of abnormal results. Can Fam Physician. 2012;58(1):e22-31.
Adam Y, McIntyre JA, De Bruyn G. Incidence of cytological abnormalities within 24 months of a normal cervical smear in Soweto, South Africa. S Afr Med J. 2012;103(1):34-9.
Siebers AG, Klinkhamer PJ, Vedder JE, Arbyn M, Bulten J. Causes and relevance of unsatisfactory and satisfactory but limited smears of liquid-based compared with conventional cervical cytology. Arch Pathol Lab Med. 2012;136(1):76-83.
Nygård JF, Sauer T, Nygård M, Skare GB, Thoresen SØ. CIN 2/3 and cervical cancer in an organised screening programme after an unsatisfactory or a normal Pap smear: a seven-year prospective study of the Norwegian population-based screening programme. J Med Screen. 2004;11(2):70-6.
Gavranović L, Novak SR, Bolanca IK. [Causes and frequency of unsatisfactory cervicovaginal smears]. Acta Med Croatica. 2011;65 Suppl 1:115-9.
American Society for Colposcopy and Cervical Pathology. Management guidelines. Available from: www.asccp.org /Guidelines-2/Management-Guidelines-2. Accessed in 2013 (Dec 18).
